Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Kathryn S. McKee"'
Autor:
Heather Lin, Peter Langmuir, Hai T. Tran, Shaoyu Yan, J. Jack Lee, John V. Heymach, Emer O. Hanrahan, Anderson J. Ryan, Edward S. Kim, Kathryn S. McKee, Bruce E. Johnson, D. Z. Du
Purpose There is an unmet need for biomarkers for identifying patients likely to benefit from anticancer treatments, selecting dose, and understanding mechanisms of resistance. Plasma vascular endothelial growth factor (VEGF) and soluble VEGF recepto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7239137057de415b1c6832552c96873b
https://ora.ox.ac.uk/objects/uuid:74acf8d2-84c4-425d-ae6a-c9b0bec7ab47
https://ora.ox.ac.uk/objects/uuid:74acf8d2-84c4-425d-ae6a-c9b0bec7ab47
Autor:
Mehrdad Khajavi, John V. Heymach, Amado J. Zurita, Christopher J. Logothetis, Hai T. Tran, Kathryn S. McKee, Nizar M. Tannir, Matthew H. Herynk, D. Z. Du, Lei Xu, Shaoyu Yan, Eric Jonasch, X. Wang
Publikováno v:
Annals of Oncology. 23:46-52
Background: We investigated cytokines and angiogenic factors (CAFs) in patients with metastatic renal cell carcinoma (mRCC) treated in a randomized phase II clinical trial of sorafenib versus sorafenib+ interferon-a (IFN-a) that yielded no difference
Autor:
Toshiko Yamochi, Chikao Morimoto, Ugur Aytac, Kathryn S. McKee, Tadanori Yamochi, Tsutomu Sato, Nam H. Dang, Kei Ohnuma
Publikováno v:
Cancer Research. 65:6950-6956
CD26 is an antigen with key role in T-cell biology and is expressed on selected subsets of aggressive T-cell malignancies. To elucidate the role of CD26 in tumor behavior, we examine the effect of CD26 depletion by small interfering RNA transfection
Autor:
Kazuya Sato, Nam H. Dang, Kei Ohnuma, Toshiko Yamochi, Kathryn S. McKee, Chikao Morimoto, Tadanori Yamochi, Ugur Aytac, Tsutomu Sato
Publikováno v:
Cancer Research. 65:1973-1983
CD26 is a Mr 110,000 surface-bound glycoprotein with diverse functional properties, including having a key role in normal T-cell physiology and the development of certain cancers. In this article, we show that surface expression of CD26, especially i
Publikováno v:
Pediatric Research. 27:525-528
Lactoferrin has been identified as a factor in human colostrum that accounts for increased incorporation of thymidine into the DNA in an in vitro rat crypt enterocyte bioassay. We have examined lacatoferrin-stimulated thymidine incorporation by compa
Autor:
John V. Heymach, Surena F. Matin, Eric Jonasch, Hai T. Tran, Xuemei Wang, Mehrdad Khajavi, Christopher G. Wood, Amado J. Zurita, Stefania Fiorentino, Kathryn S. McKee
Publikováno v:
Web of Science
e15075 Background: Although recent years have brought great progress into understanding the pathogenesis of RCC and multiple promising biomarkers, no tumor tissue or blood-based test has yet been established to assist in the clinical determination of
Autor:
Stefania Fiorentino, Surena F. Matin, Amado J. Zurita, Xuemei Wang, John V. Heymach, Hai T. Tran, Mehrdad Khajavi, Christopher G. Wood, Eric Jonasch, Kathryn S. McKee
Publikováno v:
Journal of Clinical Oncology. 30:383-383
383 Background: Although recent years have brought great progress into understanding the pathogenesis of RCC and multiple promising biomarkers, no tumor tissue or blood-based test has yet been validated for clinical use. The main objectives of this e
Autor:
Mehrdad Khajavi, John V. Heymach, Shaoyu Yan, Hai T. Tran, Peter F.A. Mulders, Amado J. Zurita, Bijoyesh Mookerjee, Laura Pike, Juliane M. Jürgensmeier, Kathryn S. McKee
Publikováno v:
Journal of Clinical Oncology. 29:362-362
362 Background: Cediranib is a highly potent and selective signaling inhibitor of vascular endothelial growth factor (VEGF) receptors−1, −2, −3 and c-Kit. In a phase II trial, patients (pts) with mRCC were randomized 3:1 to treatment with cedir
Autor:
D. Z. Du, Lei Xu, Eric Jonasch, Nizar M. Tannir, X. Wang, Amado J. Zurita, Kathryn S. McKee, Matthew H. Herynk, Shaoyu Yan, John V. Heymach, Hai T. Tran
Publikováno v:
Journal of Clinical Oncology. 27:5114-5114
5114 Background: SR, an oral inhibitor of Raf kinase, RET-receptor (R), VEGFR-1, 2, and 3, PDGFR-β, FLT-3, and c-KIT tyrosine kinases, has been shown to prolong progression-free survival (PFS) in mRCC after cytokine failure. In a phase II trial, mRC
Autor:
J. Drevs, Kathryn S. McKee, John V. Heymach, Thomas A. Puchalski, Amado J. Zurita, Jane Robertson, Hua-Kang Wu, Ute Zirrgiebel, Juliane M. Jürgensmeier
Publikováno v:
Journal of Clinical Oncology. 26:14687-14687
14687 Background: Recent studies suggest that specific subpopulations of monocytes and myeloid progenitors, particularly those expressing VEGFR-1, play a key role in promoting tumor angiogenesis an...